These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36859639)

  • 1. Systems Medicine for Precise Targeting of Glioblastoma.
    Zeng J; Zeng XX
    Mol Biotechnol; 2023 Oct; 65(10):1565-1584. PubMed ID: 36859639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic pathways and glioblastoma treatment.
    Clarke J; Penas C; Pastori C; Komotar RJ; Bregy A; Shah AH; Wahlestedt C; Ayad NG
    Epigenetics; 2013 Aug; 8(8):785-95. PubMed ID: 23807265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
    Yu W; Liang S; Zhang C
    Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
    Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
    Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of glioblastoma (GBM) molecular classification methods.
    Lee E; Yong RL; Paddison P; Zhu J
    Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks.
    Chen L; Kang C
    Oncotarget; 2015 Nov; 6(36):38628-42. PubMed ID: 26439688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care.
    Habib A; Pease M; Kodavali CV; Amankulor N; Zinn PO
    J Neurooncol; 2021 Jan; 151(2):103-112. PubMed ID: 33394264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective of mesenchymal transformation in glioblastoma.
    Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
    Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
    C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
    Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.
    Rahman R; Trippa L; Alden S; Fell G; Abbasi T; Mundkur Y; Singh NK; Talawdekar A; Husain Z; Vali S; Ligon KL; Wen PY; Alexander BM
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):716-724. PubMed ID: 32417407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening.
    Fang Y; Li X; Tian R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of glioma.
    Marumoto T; Saya H
    Adv Exp Med Biol; 2012; 746():2-11. PubMed ID: 22639155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear respiratory factor 1 transcriptomic signatures as prognostic indicators of recurring aggressive mesenchymal glioblastoma and resistance to therapy in White American females.
    Bhawe K; Das JK; Yoo C; Felty Q; Gong Z; Deoraj A; Liuzzi JP; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Komotar RJ; Roy D
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1641-1682. PubMed ID: 35441887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances of the regulation roles of MicroRNA in glioblastoma.
    Yan C; Kong X; Gong S; Liu F; Zhao Y
    Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.
    Wang Y; Yang CH; Schultz AP; Sims MM; Miller DD; Pfeffer LM
    J Cell Mol Med; 2021 Mar; 25(6):2956-2966. PubMed ID: 33528916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards deciphering glioblastoma intra-tumoral heterogeneity: The importance of integrating multidimensional models.
    Sajid RS; van Winden LJ; Diamandis P
    Proteomics; 2023 Nov; 23(21-22):e2200401. PubMed ID: 37488996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.